Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
21 August, 2018 15:22 IST
Panacea Biotec receives EIR for oncology manufacturing facility
Source: IRIS | 12 Mar, 2018, 10.40AM
Comments  |  Post Comment

Panacea Biotec announced the receipt of Establishment Inspection Report (EIR) from the U.S. Food & Drug Administration ('USFDA') indicating the formal closure of the Inspection conducted by USFDA, at its Pharmaceutical Formulation Facility for Oncology Parenteral and Oral Solids Dosage at Malpur, Baddi, District Solan, Himachal Pradesh, India.

Shares of the company gained Rs 9.7, or 3.45%, to trade at  Rs 290.75.  The total volume of shares traded  was  12,527 at the BSE (10.29 a.m., Monday).



Panacea Biotec Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Jet Airways expands codeshare agreement with Bangkok airways - 21-Aug-2018 11:46
Man Infraconstruction intimates of arbitral award in favour of subsidiary Manaj Tollway - 21-Aug-2018 10:44
Lupin receives FDA approval for generic Hydrocortisone Butyrate Lotion - 21-Aug-2018 10:36
Tanla Solutions acquires Karix Mobile for Rs 3.40 bn - 21-Aug-2018 09:31
Indian Hume Pipe Co bags work order worth Rs 2.56 bn - 20-Aug-2018 16:17
Multi Commodity Exchange of India signs MoU with Indian Cotton Federation - 20-Aug-2018 16:12
Ratnamani Metals & Tubes wins orders worth Rs 1.55 bn - 20-Aug-2018 10:00
Ion Exchange receives EPC contract worth Rs 4.38 bn - 17-Aug-2018 11:35
IL&FS Transportation Networks to receive Rs 430 mn from Ramky Infra - 17-Aug-2018 11:32
IL&FS Transportation Networks to receive Rs 430 mn from Ramky Infra - 17-Aug-2018 11:32
Ashok Leyland wins overseas order for 300 double decker buses - 17-Aug-2018 09:51
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer